Annals of Pulmonology

 ISSN: 2643-5985

Home / Annals of Pulmonology / Editorial Board / Dr. Abdelbary Elhissi

Editorial board member | Dr. Abdelbary Elhissi

Dr. Abdelbary Elhissi

Associate Professor
College of Pharmacy
Qatar University
Tel: +974-4403-5632

Dr Abdelbary Elhissi combines a profound expertise in higher education, industry, and research. He obtained his PhD (2001-2005) and a post-doctoral research fellowship (2005-2006) from The School of Pharmacy, University College London, UK. He worked in pharmaceutical industry at Lipoxen Technologies, London as Senior Scientist for development of anticancer nanomedicines (2006-2007). He then worked at University of Central Lancashire (UCLan) as lecturer and then Senior Lecturer in pharmaceutics (2007-2014), where he established one of the largest drug delivery groups in the UK, with main focus on pulmonary drug delivery. He was the founding leader of The Drug Delivery Group and the Deputy Head and a founding member of the UCLan’s Institute of Nanotechnology and Bioengineering (2011-2014). Dr Elhissi is a visiting fellow at London South Bank University, a visiting professor at Sichuan university in China and an external examiner in a number of other universities. He has research collaborations with prestigious universities in UK, USA, Egypt, China and Pakistan. Dr Elhissi authored more than 60 peer-reviewed research papers and book chapters, more than 70 conference abstracts, 3 books, and 1 filed patent. He generated/contributed to generating around £1,275,000 research income in addition to $700,000 NPRP 9th cycle. Dr Elhissi teaches in both undergraduate and graduate courses, including physical pharmacy, preformulation, biopharmaceutics, drug delivery, drug development, nanomedicine and radiopharmacy. He also gives advanced training to graduate students on presentation skills, and writing and reviewing research papers and grant proposals. Dr Elhissi is currently an Associate Professor at College of Pharmacy (Canadian accredited BSc Pharmacy), Qatar University (September 2014- Present).